Suppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model
about
Immediate-type hypersensitivity drug reactionsDiclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolitesAnti-acid medication as a risk factor for food allergy.Development of food allergies in patients with gastroesophageal reflux disease treated with gastric acid suppressive medications.Allergic diseases and asthma in pregnancy, a secondary publication.The role of proton pump inhibitor therapy in the management of eosinophilic esophagitis.Rapid analysis of diclofenac in freshwater and wastewater by a monoclonal antibody-based highly sensitive ELISA.The Efficacy and Tolerability of a Triple Therapy Containing a Potassium-Competitive Acid Blocker Compared With a 7-Day PPI-Based Low-Dose Clarithromycin Triple Therapy.Acid suppression therapy and allergic reactions.Proton pump inhibitors are associated with hypersensitivity reactions to drugs in hospitalized patients: a nested case-control in a retrospective cohort study.Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010.Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.Safety of first-line triple therapy with a potassium-competitive acid blocker for Helicobacter pylori eradication in children.Importance of hypersensitivity in adverse reactions to drugs in the elderly.Hypersensitivity Reactions to Proton Pump InhibitorsThe Effect of Digestion and Digestibility on Allergenicity of Food
P2860
Q26995860-0828DBD4-217E-4A58-978A-231B6842D5F0Q28475945-E430808D-C4E8-40FD-BAA0-0F8FDE0D4A77Q34625515-3F262B5D-A2F5-4567-B57D-2AE516535257Q35927106-B77CD17F-55A8-4196-9692-700416D37833Q37676741-9561804D-9C18-4133-AEF4-05EDAC901ECCQ38813019-759A3235-88CC-42EE-85AF-EDE8C74CEC2FQ40463555-657F47A4-0CC2-4D06-A8F9-C9048A1E2631Q40672521-1D20F475-0176-4B63-9D32-16588FF4BEF1Q42024011-14F06097-0B41-49AB-8D06-2C0C7F14E886Q43749235-D9306467-D5DD-4AFD-84BF-2E6A0435FF6CQ43888450-4D132793-93DF-4BFC-BC3D-6E54CC316F3DQ45940909-C411B299-967C-4A21-AC24-5DF35D2A736BQ47225018-E1598D5C-F6D9-4146-BC10-2193C07BDC24Q55266156-8A2C8050-1476-470D-B91D-A79C0679D77AQ56431956-36A6CAF1-FD07-4A21-8B20-EEB455A5AACAQ58725837-91528329-2BDD-42B6-9C9E-A0A4C814171E
P2860
Suppression of gastric acid increases the risk of developing immunoglobulin E-mediated drug hypersensitivity: human diclofenac sensitization and a murine sensitization model
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Suppression of gastric acid in ...... d a murine sensitization model
@ast
Suppression of gastric acid in ...... d a murine sensitization model
@en
Suppression of gastric acid in ...... d a murine sensitization model
@nl
type
label
Suppression of gastric acid in ...... d a murine sensitization model
@ast
Suppression of gastric acid in ...... d a murine sensitization model
@en
Suppression of gastric acid in ...... d a murine sensitization model
@nl
prefLabel
Suppression of gastric acid in ...... d a murine sensitization model
@ast
Suppression of gastric acid in ...... d a murine sensitization model
@en
Suppression of gastric acid in ...... d a murine sensitization model
@nl
P2093
P2860
P1476
Suppression of gastric acid in ...... d a murine sensitization model
@en
P2093
E Untersmayr
I Pali-Schöll
T Kinaciyan
P2860
P304
P356
10.1111/J.1365-2222.2009.03363.X
P577
2009-10-07T00:00:00Z